Long-term evolution of N-terminal pro-brain natriuretic peptide levels and exercise capacity in 132 left ventricular assist device recipients.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  European Journal of Cardio-Thoracic Surgery

• Publication date

  2022-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ejcts/ezac053PMID 35143640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Limiting factors of peak and submaximal exercise capacity in LVAD patients

  2020cited by this paper
• Improved 6 Minute Walk Distance and Brain-Type Natriuretic Peptide After Continuous-Flow Ventricular Assist Device Placement in Children.

  2019cited by this paper
• Physical Activity Is Higher in Patients with LVADs Compared to Chronic Heart Failure.

  2019cited by this paper
• Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

  2019cited by this paper
• Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients.

  2019cited by this paper
• Changes in Total Cardiac Output and Oxygen Extraction During Exercise in Patients Supported With an HVAD Left Ventricular Assist Device

  2018cited by this paper
• LVAD Pump Flow Does Not Adequately Increase With Exercise

  2018cited by this paper
• Exercise capacity in left ventricular assist device patients with full and partial support

  2017cited by this paper
• Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow.

  2016cited by this paper
• Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.

  2016cited by this paper
• Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.

  2015cited by this paper
• Exercise in heart failure patients supported with a left ventricular assist device.

  2015cited by this paper
• Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.

  2014cited by this paper
• Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure.

  2014cited by this paper
• Exercise hemodynamics during extended continuous flow left ventricular assist device support: the response of systemic cardiovascular parameters and pump performance.

  2013cited by this paper
• The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP.

  2012cited by this paper
• Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival.

  2012cited by this paper
• Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling

  2011cited by this paper
• B-Type Natriuretic Peptide Levels and Continuous-Flow Left Ventricular Assist Devices

  2010cited by this paper
• Natriuretic peptides.

  2007cited by this paper
• Use of a continuous-flow device in patients awaiting heart transplantation.

  2007cited by this paper
• Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.

  2006cited by this paper
• Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.

  2005cited by this paper
• brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure.

  2002cited by this paper
• Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

  2001cited by this paper
• Six minute walking distance in healthy elderly subjects.

  1999cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper

• Anästhesie bei Patient:innen mit Linksherzunterstützungssystemen

  2025cites this paper
• Diaphragm Training in Patients With Left Ventricular Assist Devices: A Narrative Review of Rehabilitation and Clinical Implications

  2025cites this paper
• The state of left ventricular device therapy for advanced heart failure: midway upon the journey towards euvolemia and full functional recovery.

  2022cites this paper